Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,701 | 25,508 | 28,468 | 30,401 | 40,235 |
| Marketable Securities | 81,307 | 97,460 | 113,897 | 135,562 | 145,193 |
| Receivables | 67 | 79 | 30 | 234 | 146 |
| TOTAL | $112,666 | $129,524 | $149,066 | $170,004 | $188,631 |
| Non-Current Assets | |||||
| PPE Net | 6,618 | 6,981 | 6,886 | 7,057 | 6,370 |
| Other Non-Current Assets | 11,656 | 12,357 | 13,439 | 14,202 | 14,580 |
| TOTAL | $18,274 | $19,338 | $20,325 | $21,259 | $20,950 |
| Total Assets | $130,940 | $148,862 | $169,391 | $191,263 | $209,581 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 355 | 848 | 1,215 | 2,036 | 1,121 |
| Accrued Expenses | 9,600 | 7,026 | 5,838 | 6,375 | 7,392 |
| Other current liabilities | 73 | 73 | 73 | 73 | N/A |
| TOTAL | $13,087 | $11,119 | $10,768 | $12,204 | $12,253 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,883 | 8,519 | 9,582 | 10,265 | 10,643 |
| TOTAL | $7,883 | $8,519 | $9,582 | $10,276 | $10,687 |
| Total Liabilities | $20,970 | $19,638 | $20,350 | $22,480 | $22,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,717 | 24,545 | 24,426 | 24,363 | 24,363 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -330,549 | -309,777 | -288,249 | -266,995 | -246,684 |
| Other shareholders' equity | 103 | 87 | 2 | 0 | -129 |
| TOTAL | $109,970 | $129,224 | $149,041 | $168,783 | $186,641 |
| Total Liabilities And Equity | $130,940 | $148,862 | $169,391 | $191,263 | $209,581 |